ArticleACS medicinal chemistry letters2021

Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies.

John W Lampe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.